We endeavored here to shed light on the supply of glutathione (GSH) precursors from glial cells to neurons and on the interference of ammonia with this process. Administration of ammonium chloride (ammonia) via a microdialysis probe to the rat prefrontal cortex rapidly increased GSH content in the microdialysates. The increase was abrogated by the inhibitor of astrocytic energy metabolism fluoroacetate and the inhibitor of glutathione synthesis buthionine sulfoximine. GSH in the microdialysates was significantly elevated in rats with simple hyperammonemia (HA) or hepatic encephalopathy (HE) (three ip administrations of ammonium acetate or thioacetamide, respectively, at 24-h intervals), only when microdialysis was carried out in the presence of a g-glutamyltranspeptidase (gGT) inhibitor acivicin. Extracellular GSH increased in cultured rat cortical astrocytes treated with 5mM ammonia for 1 h, but not for 3-72 h, which was the period of increased gGT activity. GSH remained increased during the whole 72-h incubation with 5 or 10mM ammonia in C6 glioma cells, where gGT activity is intrinsically low and was not increased by ammonia. Collectively, the results suggest that in rats with HA or HE ammonia specifically promote GSH synthesis and export from astrocytes and increase its extracellular degradation, which may improve the availability of precursors for GSH synthesis in neurons and their resistance to ammonia toxicity.
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Accumulation of ammonia in the brain is a major causative factor in hepatic encephalopathy (HE) and other hyperammonemic encephalopathies. Astrocytes are the cells that primarily metabolize blood-derived ammonia and are as such the primary line of defense against ammonia neurotoxicity, being themselves subject to ammonia-induced metabolic impairment (for reviews see Albrecht and Jones, 1999; Butterworth, 2007; Felipo and Butterworth, 2002; Rao et al., 2005) . There is a consensus that oxidative stress in astrocytes and/or neurons plays an important role in the complex mechanisms underlying ammonia neurotoxicity (Kosenko et al., 2003; Rao et al., 2005; Reinehr et al., 2007) . Because glutathione is a major antioxidant in the brain, its level and cellular distribution may be instrumental for the ability of central nervous system cells to counteract the deleterious effects of ammonia.
In vitro experiments have demonstrated that glutathione (GSH) synthesized in astrocytes is a source of precursors for GSH synthesis in neurons. The precursors glycine (Gly), cysteine (Cys), and the dipeptide CysGly are generated by extracellular GSH degradation mediated by c-glutamyltranspeptidase (cGT) (Dringen et al., 1999; Sagara et al., 1993) or by spontaneous reduction of extracellular cystine to cysteine by reduced GSH (Wang and Cynader, 2000) . Accordingly, in astrocyte/neuron cocultures, glutathione synthesis in astrocytes elevates the GSH content in neurons (Gegg et al., 2005) The spontaneous or evoked upregulation of GSH synthesis also decreases neuronal damage in response to nitric oxide (Chen et al., 2001) which specifically stimulates GSH synthesis in astrocytes (Gegg et al., 2003) . Similar neuroprotective responses have been reported in cultures exposed to methylmercury (Morken et al., 2005) , 6-OH-dopamine (Sandhu et al., 2009) or the excess of glutamate (Glu) (Shih et al., 2003) , in which case the protective action possibly involves the Gluinduced GSH release from astrocytes (Frade et al., 2008) .
Ammonia increases GSH synthesis in cultured astrocytes. The increase is facilitated by activation of the uptake of the GSH precursor cystine (Węgrzynowicz et al., 2007) . Neurons which in hyperammonemic conditions in situ are relatively well protected by astrocytes against ammonia toxicity, undergo necrotic and apoptotic damage when exposed to ammonia in the absence of astrocytes. This is correlated with a drop in the GSH:GSSG ratio, reflecting the lack of ability to upregulate GSH synthesis (Klejman et al., 2005) . We speculated therefore that the ammonia-induced increase in GSH synthesis in astrocytes may, in addition to serving autoprotective purposes, increase the availability of precursors for neuronal GSH synthesis. This sequence of events may contribute to the relative resistance of neurons to ammonia.
Recently, we observed that intracerebral administration of ammonia via a microdialysis probe markedly increases the glutathione content in prefrontal cortex (PFC) microdialysates, representing alterations in the extracellular space (Węgrzynowicz et al., 2007) . This finding prompted us to test the hypothesis that a surplus of extracellular GSH indeed is derived from its increased synthesis in astrocytes. To this end, we analyzed GSH accumulation in PFC microdialysates upon ammonia infusion in the presence or absence of fluoroacetate (FA), which specifically inhibits the astrocytic aconitase (Fonnum et al., 1997) , and of buthionine sulfoximine (BSO), an inhibitor of GSH synthesis (Griffith and Meister, 1979 ). Next, we tested whether the effect of acute intracerebral ammonia administration can be reproduced in authentic hyperammonemia (HA) models. We measured the GSH content of PFC microdialysates in rats subjected to two models of prolonged (3 ip administrations at 24-h intervals) HA. One model was based on the administration of ammonium acetate (AAC), which produces simple HA (Hilgier and Olson, 1994) , and the other one employing a hepatotoxin, thioacetamide (TAA), which produces effects mimicking acute-to-subacute HE (Hilgier and Albrecht, 1983; Hilgier and Olson, 1994) .
Earlier studies from our laboratory have demonstrated that cGT activity is increased in homogenates of different regions and cell fractions derived from the brains of rats with HE (Stastný et al., 1988) and HA (Hilgier et al., 1990) . In the present study, we addressed two pertinent questions: (1) Does the increased cGT activity contribute to more active metabolism of extracellular GSH? and (2) Is this increase located in astrocytes? To answer question (1), we compared extracellular GSH accumulation in the PFC of HA and HE rats in the presence and absence of a cGT inhibitor, acivicin (ACV). With regard to question (2), we compared the time course of the effects of ammonia treatment on the extracellular GSH accumulation and cGT activity in cultured cortical astrocytes. The correlation between the GSH accumulation and cGT activity was also assessed in ammonia-treated C6 cells, an astroglioma cell line which in a previous study was shown to accumulate GSH intracellularly following ammonia treatment (Węgrzynowicz et al., 2007) .
MATERIALS AND METHODS
HE and HA models in rats. Acute HA or HE were produced in adult male Wistar rats exactly as described before (Hilgier and Albrecht, 1983; Hilgier and Olson, 1994 , and references therein). The rats were given three ip injections of AAC (600 mg/kg body weight) or TAA (250 mg/kg body weight) at 24-h intervals and sacrificed 24 h after the last administration. In both models, serum and brain ammonia increased to similar levels (to~200% of control). Serum transaminase activities increased 10-fold in the animals injected with TAA but were unchanged in the animals given AAC injections. However, both HA and HE rats showed alterations in the cerebral cortex typical of hyperammonemic encephalopathy, including an increased glutamine content and a decreased tissue-specific gravity indicating edema formation (Hilgier and Olson, 1994) .
Microdialysis. Adult male Sprague-Dawley rats (220-280 g) were used for microdialysis experiments. The procedure was in accordance with the European Community Directive for the ethical use of experimental animals. Following an initial anesthesia (4% halothane in air for 2 min), the rats were placed in a stereotactic frame and maintained under general anesthesia (1% halothane in air at 1.2 l/min) until the end of the experiment. The skin was cut in the middle of the head, a hole drilled in the skull, and the microdialysis probe (dialysis membrane: diameter 0.5 mm, length 3 mm, cutoff: 20 kDa; CMA Microdialysis) was stereotactically implanted into the left PFC (coordinates: anteroposterior þ3.0 to 3.2 mm; mediolateral À0.6 mm; dorsoventral À3.0 to 4.0 mm) (Paxinos and Watson, 1982) . Artificial cerebrospinal fluid (aCSF; 10mM glucose, 126mM NaCl, 27mM NaHCO 3 , 2.4mM KCl, 0.5mM Na 2 SO 4 , 0.5mM KH 2 PO 4 , 1.1mM CaCl 2 , 0.8mM MgCl 2 , pH 7.4) was pumped through the probe at a flow rate of 2.5 ll/min. The collection of microdialysates was initiated 30 min after the probe implantation, and the fractions were collected every 40 min. The compounds used in the experiments were provided in the aCSF directly to tissue through the microdialysis probe. BSO (10mM), FA (50mM), or ACV (1mM) was administered for the entire duration of the experiment. Ammonium chloride (NH 4 Cl; 60mM) was infused for 40 min (from 120th to 160th min). This concentration of NH 4 Cl was chosen because, as previously calculated from the probe efficiency trial, it rendered from the start of the infusion 5mM extracellular ammonia, a concentration reached in the brain in acute HA (Zielińska et al., 2002) . Experiments were terminated after collection of the sixth fraction, the rats were decapitated, and the microdialysates were frozen at À20°C and used for glutathione assays.
Cell cultures. Primary cultures of astrocytes were prepared according to Hertz et al. (1989) with some modifications. One-day-old Wistar rats were decapitated, and the cortex was isolated and passed through the Nitex nylon net with 80-and 41-lm mesh. Cells were grown in 35-mm dishes at 37°C in Dulbecco's modified Eagle's medium (DMEM) supplemented with 20% fetal bovine serum (FBS), penicillin (50 U/ml), and streptomycin (50 lg/ml) in the atmosphere of 10% CO 2 in air. The medium was changed twice a week and the FBS content was gradually decreased to 10% at day in vitro (DIV) 14. To induce differentiation of astrocytes, 0.25mM dibutyryl-cAMP was added from DIV 7 onwards. The cells were used for the experiments 3-4 weeks after plating.
Rat glioma C6 cells were cultured in 35-mm dishes at 37°C in DMEM supplemented with 5% FBS in the atmosphere of 10% CO 2 in air. The experiments were performed 3-6 days after inoculation.
NH 4 Cl (final concentration of 5 mmol or 10 mmol/l) or vehicle was added into the medium covering the cells for 1-72 h. The medium was collected for the extracellular GSH content assays, deproteinized by mixing with 30% perchloric acid (ratio 10:1), and centrifuged at 20,000 3 g for 12 min. To increase the efficiency of GSH derivatization for high-performance liquid chromatography (HPLC) measurements (Paroni et al., 1995) , pH of the supernatant was adjusted to 7.0 using Na 2 CO 3 . The samples were again centrifuged at 20,000 3 g for 12 min and used for glutathione measurements.
GSH measurement. Glutathione (total, i.e., reduced + oxidized, designated in figures and figure legends as GSx) was measured using the HPLC method with fluorimetric detection as described by Neuschwander-Tetri and Roll (1989) with some modifications. To reduce oxidized GSH, the samples were incubated for 30 min with 20mM dithiothreitol at 4°C. Before separation, GSH was derivatized with orthophthalaldehyde (OPA) by 1-min incubation with an equal volume of borate buffer, pH 10.0, containing 1.5mM OPA and 0.25% b-mercaptoethanol (Simons and Johnson, 1976) . The samples were eluted isocratically with the mobile phase consisting of 50mM phosphate buffer, pH 6.2 (75%), and methanol (25%) through the C-18 column at 1.2 ml/min. The fluorescent GSH derivative was measured at the wavelengths: excitation 370 nm and emission 450 nm. After each run, the column was washed with 80% ethanol.
Assay of cGT activity. cGT kit (Pointe Scientific, Canton, MI) containing l-c-glutamyl-3-carboxy-4-nitroanilide and glycylglycine was used. With these two reagents, cGT produces 5-amino-2-benzoate, which can be measured spectrophotometrically. The reaction velocity was measured for 6 min at 37°C at 405 nm. The enzyme activity was calculated using Lambert-Beer equation knowing that the millimolar absorption coefficient for 5-amino-2-benzoate at 405 nm is 9.5.
Protein measurement. The content of extracellular glutathione and the activity of cGT were normalized to the protein levels in astrocytes or C6 cells. To extract protein, the cells were washed 33 with PBS and subsequently incubated for 30 min with 1M NaOH at 37°C. Bradford (1976) method was used for protein assays. The samples were mixed (ratio 9:1) with Coomassie blue (100 lg/ml) in 5% ethanol and 10% H 3 PO 4 and measured spectrophotometrically at 595 nm.
RESULTS
An infusion of ammonia to the PFC for 20 min increased the extracellular (microdialysate) GSH content by 180% above the basal level (Figs. 1A and 1B) . Extracellular GSH did not exceed the basal level when ammonia was coinfused with BSO ( Fig. 1A) or FA (Fig. 1B) , indicating that the surplus of extracellular GSH was due to its increased synthesis in astrocytes. In HA in the AAC model, the extracellular glutathione concentration in the PFC only increased when the superfusion was carried out in the presence but not in the absence of the cGT inhibitor ACV (Fig. 2) . In HE in the TAA model, a marked increase in the extracellular glutathione concentration was noted when the superfusion was carried out in the presence of ACV, whereas the increase was only slight (albeit statistically significant) upon perfusion in the absence of ACV (Fig. 3) .
Treatment with 5mM (but not with 10mM) ammonia for 1 h increased by 33% the extracellular GSH content in astrocytes, but the stimulation was confined to this short incubation time and dose (Fig. 4A) . In C6 glioma cells, an increase in extracellular GSH was first observed after 3 h of incubation with 5 or 10mM ammonia and persisted during the 72-h incubation in the presence of one or both ammonia doses (Fig. 4B) . The ammonia-treated astrocytes showed a significant increase in the cGT activity at all incubation time points except at 3 h, the response being statistically significant for both 5 and 10mM ammonia after 1 and 72 h of incubation. Only one of the doses was significantly effective at 24 and 48 h of incubation (Fig. 5A) . However, in C6 cells, the cGT activity was not affected by ammonia at any dose or incubation time (Fig. 5B) .
DISCUSSION
A recent study from our laboratory has revealed that the intracerebral infusion of ammonia in vivo increases the accumulation of GSH in the extracellular space of the PFC (Węgrzynowicz et al., 2007) . Because application of ammonia in vitro increases GSH synthesis and accumulation in cultured astrocytes (Murthy et al., 2000; Węgrzynowicz et al., 2007) but not in cultured neurons (Klejman et al., 2005) , we speculated that the increase in extracellular GSH following ammonia treatment in vivo is likewise due to the stimulation of synthesis and release from astrocytes. This was an attractive idea because astrocytic GSH, apart from serving as a protectant against astrocytic damage, could generate precursors for GSH synthesis in neurons, in this manner protecting neurons against ammonia neurotoxicity. A plethora of studies indicate that astrocytes synthesize, and contain, more GSH than neurons and that astrocytic GSH is the source of precursors for neuronal GSH synthesis (Dringen et al. 2000 and references therein) . In accordance with this sequence of events, astrocytic GSH protects neurons against damage invoked by different noxious agents (Chen et al., 2001; Morken et al., 2005; Sandhu et al., 2009; Shih et al., 2003) . However, the evidence quoted above favoring the shuttle of GSH precursors from astrocytes to neurons and the role of this process in neuroprotection has been AMMONIA NEUROTOXICITY AND GLUTATHIONE mostly derived from in vitro studies using cultured astrocytes and neurons or astrocyte/neuron cocultures. The evidence in vivo is scarce; to the authors' knowledge, it is confined to the demonstration of an increased synthesis and outflow of GSH and/or its metabolites in the rat striatum in response to conditions mimicking oxidative stress (Han et al., 1999; Foster et al., 2005) . Moreover, the astrocytic origin of GSH was not verified in the former studies. The present observations on the increased amounts of GSH in PFC microdialysates following superfusion with ammonia, an increase which was blocked by coapplication of (1) BSO, a specific inhibitor of GSH synthesis, and (2) of FA, which effectively and specifically arrests astrocytic aconitase and thus astrocytic energy metabolism (Dopico et al., 2006; Fonnum et al., 1997; Rodríguez Díaz et al., 2005) , strongly indicate that acute ammonia treatment specifically upregulates the synthesis and export of astroglia-derived GSH to the extracellular space in situ.
Durable (3-day) HA associated with administration of AAC (''simple'' HA) or TAA-induced liver failure resulted in a significant increase of GSH in PFC microdialysates only when the fractions were collected in the presence of the specific cGT inhibitor ACV. This is in contrast with the stimulatory effect of direct short-term ammonia infusion, which became discernible in the absence of cGT inhibition. The basal extracellular GSH content reflects the dynamic equilibrium between GSH synthesis, export, and degradation, whereas the GSH content measured in the presence of ACV reflects the rate of its accumulation Hultberg, 2004, 2005) . In the previous studies, a large increase in GSH accumulation in the presence but not in the absence of ACV has been seen in microdialysates of the rat striatum subjected to oxidative stress in vivo (Han et al., 1999) or in the oxygen-and glucosedeprived hippocampus in vitro (Li et al., 1999) . These findings have been interpreted to indicate a co-ordinated stimulation of GSH synthesis and degradation. This interpretation is likely to hold for the effects noted in the two hyperammonemic models, being consistent with the marked increase of cGT in cerebral cortical homogenates or bulk-isolated astrocytes from TAA- (Stastný et al., 1988) and AAC-treated rats (Hilgier et al., 1990) .
Stimulation of GSH turnover following prolonged ammonia treatment and astrocytic location of these events are supported by the in vitro studies. In ammonia-treated cultured astrocytes, the offset of short-lived increase in the extracellular GSH accumulation coincided with, and was very likely causally related to, the onset of the durable increase in cGT. By contrast, the ammonia-induced increase in extracellular GSH was durable in C6 cells, which by nature are impoverished in cGT activity (Mares et al., 2005) and in which ammonia failed to activate the enzyme throughout the whole incubation period.
Interestingly in this context, a durable increase of GSH synthesis and release from astrocytes has been previously observed upon their exposure to a long-acting nitric oxide donor, diethylenetriamine/NO (DETA/NO), which, in contrast to ammonia, failed to increase the cGT activity (Gegg et al., 2005) .
A previous study demonstrated that the ammonia-induced increase of GSH synthesis in cultured astrocytes is coupled to the enhanced uptake of the GSH precursor, cystine, a reaction which is mediated by the cystine antiporter xc À (Węgrzynowicz et al., 2007) . Considerable evidence suggests that in different cell types within and outside the central nervous systems, enzymes and transporters involved in GSH synthesis and release, including the xc À antiporter, are upregulated in a coordinated way by the transcription factor Nrf2 (Shih et al., 2003 and references therein). It will be therefore of interest to see whether ammonia increases Nrf2 expression and/or activity in the in vitro and/or in vivo setting.
In conclusion, the present study supports the concept that stimulation of astrocytic GSH synthesis plays a cytoprotective role in the cerebral cortex subjected to elevated ammonia concentrations. The increased amounts of GSH released from astrocytes to the extracellular space in vivo are likely to supply more precursors for neuronal GSH synthesis. The increased cGT activity, as observed in ammonia-treated astrocytes in vitro in the present study and earlier in cerebral cortical homogenates in the two in vivo hyperammonemic models, could facilitate the delivery of GSH precursors to neurons by increasing GSH degradation. It remains to be examined whether and to which degree neurons in the ammonia-exposed brain make use of the increased availability of extracellular GSH precursors to increase their GSH synthesis. 
